Kana Lessig Stemsoft Software -

As the industry moves from bench to bedside, the bottleneck often isn't the science—it’s the documentation. The Challenge of Modern Cellular Therapies

all of their CAR-T, IEC, and research work. Ensure compliance with 21 CFR Part 11, HIPAA, and GDPR. Kana Lessig Stemsoft Software

Learn more about STEMSOFT’s solutions to take control of your data today. As the industry moves from bench to bedside,

At STEMSOFT, we believe in "Scientists Helping Scientists." With nearly three decades of experience, we provide in-house expertise and a dedicated support team to ensure your informatics solutions evolve alongside your science. Learn more about STEMSOFT’s solutions to take control

Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards.